ATE515702T1 - Verfahren, mixturen, kits und zusammensetzungen bezüglich der analytbestimmung - Google Patents

Verfahren, mixturen, kits und zusammensetzungen bezüglich der analytbestimmung

Info

Publication number
ATE515702T1
ATE515702T1 AT04705571T AT04705571T ATE515702T1 AT E515702 T1 ATE515702 T1 AT E515702T1 AT 04705571 T AT04705571 T AT 04705571T AT 04705571 T AT04705571 T AT 04705571T AT E515702 T1 ATE515702 T1 AT E515702T1
Authority
AT
Austria
Prior art keywords
kits
compositions
methods
mixtures
analyte determination
Prior art date
Application number
AT04705571T
Other languages
English (en)
Inventor
Darryl J C Pappin
Michael Bartlet-Jones
Original Assignee
Life Technologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Life Technologies Corp filed Critical Life Technologies Corp
Application granted granted Critical
Publication of ATE515702T1 publication Critical patent/ATE515702T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/15—Non-radioactive isotope labels, e.g. for detection by mass spectrometry
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT04705571T 2003-01-30 2004-01-27 Verfahren, mixturen, kits und zusammensetzungen bezüglich der analytbestimmung ATE515702T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44361203P 2003-01-30 2003-01-30
PCT/US2004/002077 WO2004070352A2 (en) 2003-01-30 2004-01-27 Methods, mixtures, kits and compositions pertaining to analyte determination

Publications (1)

Publication Number Publication Date
ATE515702T1 true ATE515702T1 (de) 2011-07-15

Family

ID=32850790

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04705571T ATE515702T1 (de) 2003-01-30 2004-01-27 Verfahren, mixturen, kits und zusammensetzungen bezüglich der analytbestimmung

Country Status (7)

Country Link
US (9) US20040219685A1 (de)
EP (1) EP1588145B1 (de)
JP (2) JP4613299B2 (de)
AT (1) ATE515702T1 (de)
AU (2) AU2004209401A1 (de)
CA (1) CA2488584C (de)
WO (1) WO2004070352A2 (de)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60003177T2 (de) * 1999-03-18 2004-05-06 602531 British Columbia Ltd., Vancouver Dateneingabe für personalrechnergeräte
AU6770800A (en) * 1999-08-13 2001-03-13 Yale University Analysis of sequence tags with hairpin primers
US20020106648A1 (en) * 2000-05-05 2002-08-08 Lizardi Paul M. Highly multiplexed reporter carrier systems
US6835545B2 (en) 2000-05-08 2004-12-28 President And Fellows Of Harvard College Methods, products and treatments for diabetes
WO2002014867A2 (en) * 2000-08-11 2002-02-21 Agilix Corporation Ultra-sensitive detection systems
AU2004209401A1 (en) 2003-01-30 2004-08-19 Applied Biosystems, Llc. Methods, mixtures, kits and compositions pertaining to analyte determination
GB0306756D0 (en) * 2003-03-24 2003-04-30 Xzillion Gmbh & Co Kg Mass labels
JP4838725B2 (ja) * 2003-11-26 2011-12-14 ディーエイチ テクノロジーズ デベロップメント プライベート リミテッド クワイエットゾーン中の質量スペクトルデータの分析
EP1916527A1 (de) * 2003-11-26 2008-04-30 Applera Corporation Analyse von Massenspektraldaten in ruhigen Bereichen
JP4832312B2 (ja) * 2004-01-05 2011-12-07 ディーエイチ テクノロジーズ デベロップメント プライベート リミテッド 標識試薬および標識化分析物の混合物を含む、標識試薬、標識化分析物、およびそれらに由来するフラグメントイオン、ならびにそれらの分析方法
US7307169B2 (en) * 2004-01-05 2007-12-11 Applera Corporation Isotopically enriched N-substituted piperazines and methods for the preparation thereof
US20050147985A1 (en) * 2004-01-05 2005-07-07 Applera Corporation Mixtures of isobarically labeled analytes and fragments ions derived therefrom
US20050148087A1 (en) 2004-01-05 2005-07-07 Applera Corporation Isobarically labeled analytes and fragment ions derived therefrom
DE602005001302T2 (de) * 2004-03-01 2008-02-14 Applera Corp., Framingham Bestimmung von analytcharakteristika auf der grundlage von bindungseigenschaften
US20080206737A1 (en) * 2004-05-19 2008-08-28 Hunter Christie L Expression quantification using mass spectrometry
WO2005114700A2 (en) * 2004-05-19 2005-12-01 Applera Corporation Expression quantification using mass spectrometry
US20070054345A1 (en) * 2004-05-19 2007-03-08 Hunter Christie L Expression quantification using mass spectrometry
US8027791B2 (en) * 2004-06-23 2011-09-27 Medtronic, Inc. Self-improving classification system
US8335652B2 (en) * 2004-06-23 2012-12-18 Yougene Corp. Self-improving identification method
US20050287574A1 (en) * 2004-06-23 2005-12-29 Medtronic, Inc. Genetic diagnostic method for SCD risk stratification
US20060172319A1 (en) * 2004-07-12 2006-08-03 Applera Corporation Mass tags for quantitative analyses
US20070048752A1 (en) 2004-07-12 2007-03-01 Applera Corporation Mass tags for quantitative analyses
WO2006055615A2 (en) 2004-11-15 2006-05-26 University Of North Dakota A method for single oxygen atom incorporation into digested peptides using peptidases
WO2006086098A2 (en) 2005-01-06 2006-08-17 President And Fellows Of Harvard College Mass spectrometric methods and products
US20070207555A1 (en) * 2005-02-03 2007-09-06 Cesar Guerra Ultra-sensitive detection systems using multidimension signals
US20060183238A1 (en) 2005-02-09 2006-08-17 Applera Corporation Amine-containing compound analysis methods
US20070037286A1 (en) * 2005-02-09 2007-02-15 Subhasish Purkayastha Thyroxine-containing compound analysis methods
JP4242358B2 (ja) 2005-03-14 2009-03-25 ホシザキ電機株式会社 断熱箱体及びその製造方法
DE102005015005A1 (de) * 2005-04-01 2006-10-05 Qiagen Gmbh Verfahren zur Behandlung einer Biomoleküle enthaltenden Probe
EP1931998B1 (de) 2005-09-15 2010-06-09 Alk-Abello A/S Verfahren zur quantifizierung von allergenen
WO2007078229A1 (en) * 2006-01-05 2007-07-12 Ge Healthcare Bio-Sciences Ab Kit and method for mass labelling
US8975404B2 (en) * 2006-01-24 2015-03-10 Dh Technologies Development Pte. Ltd. Labeling reagents for analyte determination and methods and compounds used in making the same
US20070185346A1 (en) * 2006-02-03 2007-08-09 Vaidya Niteen A Kit for automated resolving agent selection and method thereof
WO2007109292A2 (en) 2006-03-21 2007-09-27 Wisconsin Alumni Research Foundation Ionizable isotopic labeling reagents for relative quantification by mass spectrometry
EP2054540B1 (de) * 2006-05-26 2014-11-26 DH Technologies Development Pte. Ltd. Markierungsreagenzien und verfahren für hydroxylierte verbindungen
US8362242B2 (en) * 2006-06-30 2013-01-29 Dh Technologies Development Pte. Ltd. Analyte determination utilizing mass tagging reagents comprising a non-encoded detectable label
US7906341B2 (en) 2006-06-30 2011-03-15 Dh Technologies Development Pte, Ltd. Methods, mixtures, kits and compositions pertaining to analyte determination
US8580534B2 (en) * 2006-06-30 2013-11-12 The University Of North Dakota Method for incorporation of two oxygen atoms into digested peptides using peptidases
EP1918714A1 (de) * 2006-11-02 2008-05-07 Koninklijke Philips Electronics N.V. Verbindungen und verfahren zur doppel-markierung von polypeptiden zum multiplexen in massenspektrometrie
EP1921081A1 (de) 2006-11-06 2008-05-14 Koninklijke Philips Electronics N.V. Verwendung von Arylboronsäuren zur Proteinmarkierung
US7951608B2 (en) * 2007-05-04 2011-05-31 Perkinelmer Health Sciences, Inc. Detecting succinylacetone
US20110159523A1 (en) * 2007-06-27 2011-06-30 Cedars-Sinai Medical Center N-terminal specific chemical labeling for proteomics applications
US20090028791A1 (en) * 2007-07-25 2009-01-29 Balatoni Julius A Dichloroacetate Analogs as Imaging Agents
US7820964B2 (en) * 2007-08-06 2010-10-26 Metabolic Analyses, Inc Method for generation and use of stable isotope patterns in mass spectral data
US7982180B2 (en) * 2007-09-10 2011-07-19 Dh Technologies Development Pte. Ltd. Methods and systems for analysis and correction of mass spectrometer data
EP2212690A4 (de) * 2007-11-06 2011-03-30 Translational Therapeutics Inc MASSENSPEKTROMETRIETEST FÜR eIF4E- UND eIF4E-REGULON -AKTIVITÄT
US8604692B2 (en) 2007-11-06 2013-12-10 Translational Therapeutics, Inc. Mass spectrometry assay for eIF4E and eIF4E regulon activity
US20110143956A1 (en) * 2007-11-14 2011-06-16 Medtronic, Inc. Diagnostic Kits and Methods for SCD or SCA Therapy Selection
WO2009064970A1 (en) * 2007-11-14 2009-05-22 Medtronic, Inc. Genetic markers for scd or sca therapy selection
EP2108957A1 (de) * 2008-04-07 2009-10-14 Koninklijke Philips Electronics N.V. Verbindungen und Verfahren zur Markierung und Affinitätsauswahl von Proteinen
GB0809488D0 (en) * 2008-05-23 2008-07-02 Electrophoretics Ltd Mass spectrometric analysis
EP2406634A4 (de) 2009-03-10 2013-06-19 Univ Maryland Isobare deuterium-markierungsreagenzien für quantitative analyse
US8592216B2 (en) 2009-04-15 2013-11-26 Wisconsin Alumni Research Foundation Labeling peptides with tertiary amines and other basic functional groups for improved mass spectrometric analysis
EP2430184A2 (de) * 2009-05-12 2012-03-21 Medtronic, Inc. Sca-risikostratifizierung durch vorhersage des ansprechens von patienten auf antiarrhythmika
US20110003395A1 (en) 2009-05-31 2011-01-06 Dh Technologies Development Pte. Ltd. Specific analysis of analytes using reagent compounds, labeling strategies, and mass spectrometry workflow
GB0916881D0 (en) * 2009-09-25 2009-11-11 Electrophoretics Ltd Mass labels
WO2011075530A1 (en) * 2009-12-15 2011-06-23 Dh Technologies Development Pte. Ltd. Analysis of amino acids and amine-containing compounds using tagging reagents and lc-ms workflow
WO2011088423A2 (en) * 2010-01-15 2011-07-21 California Institute Of Technology Isobaric tags for analyte detection and quantification
EP2528443B1 (de) * 2010-01-25 2017-01-11 DH Technologies Development Pte. Ltd. Quantitative analyse von vitamin d3, vitamin d2 und metaboliten davon
US8455818B2 (en) 2010-04-14 2013-06-04 Wisconsin Alumni Research Foundation Mass spectrometry data acquisition mode for obtaining more reliable protein quantitation
EP2572192A4 (de) 2010-05-17 2013-12-11 Uab Research Foundation Allgemeines massenspektrometrie-assay mit kontinuierlicher eluierung co-fraktionierender reporter über die massenspektrometrische erkennungseffizienz
US8835361B2 (en) * 2010-06-01 2014-09-16 The Curators Of The University Of Missouri High-throughput quantitation of crop seed proteins
WO2012027555A2 (en) 2010-08-25 2012-03-01 President And Fellows Of Harvard College Glycated cd59 peptides, their preparation, and uses thereof
US8742333B2 (en) 2010-09-17 2014-06-03 Wisconsin Alumni Research Foundation Method to perform beam-type collision-activated dissociation in the pre-existing ion injection pathway of a mass spectrometer
JP5711948B2 (ja) * 2010-12-02 2015-05-07 良雄 林 固相担持型ｓｈ基選択的標識試薬
JP5454462B2 (ja) * 2010-12-22 2014-03-26 株式会社島津製作所 クロマトグラフ質量分析装置
US8492163B2 (en) 2011-01-31 2013-07-23 Dh Technologies Development Pte. Ltd. Methods, mixtures, kits and compositions pertaining to analyte determination
MX348592B (es) 2011-02-10 2017-06-12 Harvard College Sustitutos de proteinas modificadas post-traduccionalmente y usos de los mismos.
US9040903B2 (en) 2011-04-04 2015-05-26 Wisconsin Alumni Research Foundation Precursor selection using an artificial intelligence algorithm increases proteomic sample coverage and reproducibility
US9388132B2 (en) 2011-09-15 2016-07-12 Wisconsin Alumni Research Foundation Isobaric tandem mass tags for quantitative proteomics and peptidomics
US9874575B2 (en) 2012-01-20 2018-01-23 Dh Technologies Development Pte. Ltd. Analysis of estradiol and analytes with phenolic OH using labeling chemistry and LC-MSMS workflow
US9029086B2 (en) * 2012-01-26 2015-05-12 Masood Kamali Moghaddam Detection of single and multimodal analytes
JP6272834B2 (ja) 2012-05-18 2018-01-31 ディーエイチ テクノロジーズ デベロップメント プライベート リミテッド サイト特異的誘導とｌｃ／ｍｓ／ｍｓワークフローとを使用した脳腱黄色腫症バイオマーカーのパネルの解析
WO2014013051A1 (en) 2012-07-19 2014-01-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method of predicting or diagnosing an hepatic encephalopathy in patients with cirrhosis treated with transjugular intra-hepatic porto-systemic shunt (tips)
US9366678B2 (en) 2012-10-25 2016-06-14 Wisconsin Alumni Research Foundation Neutron encoded mass tags for analyte quantification
GB201410523D0 (en) * 2014-06-12 2014-07-30 Electrophoretics Ltd Mass labels
US20170089915A1 (en) * 2015-09-30 2017-03-30 Agilent Technologies, Inc. Methods of analyte derivatization and enhanced soft ionization
GB201521903D0 (en) * 2015-12-11 2016-01-27 Electrophoretics Ltd Isorbaric mass labels
WO2018003652A1 (ja) * 2016-06-29 2018-01-04 株式会社 日立ハイテクノロジーズ 酵素反応及び質量分析方法に用いる化合物
KR20190109448A (ko) * 2017-01-31 2019-09-25 에프. 호프만-라 로슈 아게 질량 분광분석을 위한 시약
EP3711084A1 (de) * 2017-11-14 2020-09-23 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verwendungen von isobarischen etiketten in der massenspektrometrie
EP3826996A1 (de) 2018-07-24 2021-06-02 F. Hoffmann-La Roche AG Reagens für massenspektrometrie
KR20210035812A (ko) 2018-07-24 2021-04-01 에프. 호프만-라 로슈 아게 질량 분석법용 시약
CN112492881A (zh) * 2018-07-24 2021-03-12 豪夫迈·罗氏有限公司 质谱用试剂
CN112146967A (zh) * 2019-06-28 2020-12-29 Fei 公司 用于制备和递送用于带电粒子分析的生物样品的系统和方法
EP3910341A1 (de) * 2020-05-13 2021-11-17 PreOmics GmbH Probenvorbereitung für massenspektrometrie

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860581A (en) * 1972-12-27 1975-01-14 American Home Prod Preparation of 1,4-benzodiazepines
AU5940186A (en) * 1985-07-05 1987-01-08 Institut Fur Pflanzenschutzforschung 2, 6 - dimethyl - morpholine quartenary compounds
US4761415A (en) 1986-08-28 1988-08-02 Smithkline Beckman Corporation Dopamine-β-hydroxylase inhibitors
JPH01125357A (ja) 1987-11-06 1989-05-17 Dainippon Pharmaceut Co Ltd トリペプチドの誘導体
US5800992A (en) * 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5087815A (en) * 1989-11-08 1992-02-11 Schultz J Albert High resolution mass spectrometry of recoiled ions for isotopic and trace elemental analysis
US5252296A (en) * 1990-05-15 1993-10-12 Chiron Corporation Method and apparatus for biopolymer synthesis
DK51092D0 (da) * 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
AU685055B2 (en) * 1992-05-29 1998-01-15 Rockefeller University, The Method and product for the sequence determination of peptides using a mass spectrometer
GB9300883D0 (en) 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
US6495314B1 (en) 1995-09-29 2002-12-17 The Scripps Research Institute Process for characterizing proteins
US6312893B1 (en) * 1996-01-23 2001-11-06 Qiagen Genomics, Inc. Methods and compositions for determining the sequence of nucleic acid molecules
US6027890A (en) * 1996-01-23 2000-02-22 Rapigene, Inc. Methods and compositions for enhancing sensitivity in the analysis of biological-based assays
US6613508B1 (en) * 1996-01-23 2003-09-02 Qiagen Genomics, Inc. Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques
US6475807B1 (en) * 1996-04-08 2002-11-05 Smithkline Beecham Corporation Mass-based encoding and qualitative analysis of combinatorial libraries
US5780232A (en) * 1996-05-28 1998-07-14 Atom Sciences, Inc. DNA sequencing, mapping, and diagnostic processes using hybridization and stable isotope labels of DNA
US6329180B1 (en) * 1996-09-13 2001-12-11 Alex M. Garvin Genetic analysis using peptide tagged in-vitro synthesized proteins
EP0941365B1 (de) 1996-10-04 2003-06-25 Dako A/S Sonden zur detektion von mycobakterien
GB9620769D0 (en) 1996-10-04 1996-11-20 Brax Genomics Ltd Nucleic acid sequencing
CA2274587A1 (en) 1996-12-10 1998-06-18 Genetrace Systems Inc. Releasable nonvolatile mass-label molecules
EP1400599B1 (de) 1997-01-15 2007-10-03 Xzillion GmbH & CO.KG Massenmarkierte Hybridisierungssonden
NZ336768A (en) * 1997-01-23 2001-12-21 Brax Group Ltd A method of characterising polypeptides comprising cleaving polypeptide with a cleaving agent, isolating peptide fragments (followed by a second cleavage and biotinylation step) and determining the mass spectrometry (MS) signature sequence
US7056659B1 (en) 1997-07-11 2006-06-06 Xzillion Gmbh & Co. Characterizing nucleic acids
EP0990047B1 (de) 1997-07-22 2003-05-14 Qiagen Genomics, Inc. Verfahren und verbindungen zur analysierung von nukleinsaeuren durch massenspektrometrie
GB9718921D0 (en) 1997-09-05 1997-11-12 Brax Genomics Ltd Catalytically generated mass labels
AU746443B2 (en) 1997-09-15 2002-05-02 Xzillion Gmbh & Co. Kg Characterising nucleic acid by mass spectrometry
GB9823646D0 (en) * 1997-12-19 1998-12-23 Brax Genomics Ltd Compounds for mass spectrometry
US6326479B1 (en) * 1998-01-27 2001-12-04 Boston Probes, Inc. Synthetic polymers and methods, kits or compositions for modulating the solubility of same
US6428956B1 (en) 1998-03-02 2002-08-06 Isis Pharmaceuticals, Inc. Mass spectrometric methods for biomolecular screening
WO1999049293A2 (en) * 1998-03-24 1999-09-30 Boston Probes, Inc. Methods, kits and compositions pertaining to detection complexes
AU3775099A (en) * 1998-04-29 1999-11-16 Boston Probes, Inc. Methods, kits and compositions for detecting and quantitating target sequences
AU755334C (en) * 1998-08-25 2004-02-26 University Of Washington Rapid quantitative analysis of proteins or protein function in complex mixtures
US6270976B1 (en) * 1998-09-15 2001-08-07 Brax Group Limited Characterizing nucleic acid by mass spectrometry
GB9821669D0 (en) 1998-10-05 1998-12-02 Glaxo Group Ltd Chemical constructs and their uses
US6319476B1 (en) * 1999-03-02 2001-11-20 Perseptive Biosystems, Inc. Microfluidic connector
US6629040B1 (en) * 1999-03-19 2003-09-30 University Of Washington Isotope distribution encoded tags for protein identification
US6403309B1 (en) * 1999-03-19 2002-06-11 Valigen (Us), Inc. Methods for detection of nucleic acid polymorphisms using peptide-labeled oligonucleotides and antibody arrays
AU6770800A (en) 1999-08-13 2001-03-13 Yale University Analysis of sequence tags with hairpin primers
US6472156B1 (en) * 1999-08-30 2002-10-29 The University Of Utah Homogeneous multiplex hybridization analysis by color and Tm
GB0006141D0 (en) * 2000-03-14 2000-05-03 Brax Group Ltd Mass labels
AUPQ664300A0 (en) * 2000-04-03 2000-05-04 Proteome Systems Ltd Macromolecule detection
US20020106648A1 (en) 2000-05-05 2002-08-08 Lizardi Paul M. Highly multiplexed reporter carrier systems
WO2002014867A2 (en) 2000-08-11 2002-02-21 Agilix Corporation Ultra-sensitive detection systems
WO2002046770A2 (en) 2000-10-23 2002-06-13 Genetics Institute, Llc Isotope-coded ionization-enhancing reagents (icier) for high-throughput protein identification and quantitation using matrix-assisted laser desorption ionization mass spectrometry
US20020090652A1 (en) * 2000-12-22 2002-07-11 Fu Emil Wei-Ming Inverse labeling method for the rapid identification of marker/target proteins
US7045296B2 (en) * 2001-05-08 2006-05-16 Applera Corporation Process for analyzing protein samples
GB0115581D0 (en) 2001-06-26 2001-08-15 Glaxo Group Ltd Method of mass spectometry
GB0116143D0 (en) * 2001-07-02 2001-08-22 Amersham Pharm Biotech Uk Ltd Chemical capture reagent
CA2460131C (en) 2001-09-14 2006-11-21 Xzillion Gmbh & Co. Kg Mass labels
CA2466328A1 (en) 2001-11-09 2003-05-15 Bayer Healthcare Ag Isotopically coded affinity markers 3
DE60219124T2 (de) * 2001-11-16 2008-01-31 Randox Laboratories Ltd., Crumlin Verfahren und Kit zum Nachweis, oder zum Quantifizieren von, Metaboliten von Fentanyl und Metaboliten von Fentanyl Analoga
GB0130845D0 (en) 2001-12-22 2002-02-06 James Peter Analysis
EP1502102B1 (de) 2002-03-11 2009-01-14 caprotec bioanalytics GmbH Verbindungen und verfahren für die analyse des proteoms
WO2003078584A2 (en) 2002-03-11 2003-09-25 Thermo Finnigan, Llc Identifying peptide modifications
WO2003102220A2 (en) 2002-06-04 2003-12-11 The Institute For Systems Biology Methods for high throughput and quantitative proteome analysis
US7473535B2 (en) 2002-08-20 2009-01-06 The Institute For Systems Biology Chemical reagents and methods for detection and quantification of proteins in complex mixtures
US7425451B2 (en) * 2002-12-13 2008-09-16 Agilent Technologies, Inc. Triazine derivatives as universal peptide isotope tag reagents (U-PIT)
AU2004209401A1 (en) * 2003-01-30 2004-08-19 Applied Biosystems, Llc. Methods, mixtures, kits and compositions pertaining to analyte determination
GB0306756D0 (en) 2003-03-24 2003-04-30 Xzillion Gmbh & Co Kg Mass labels
US20050148087A1 (en) * 2004-01-05 2005-07-07 Applera Corporation Isobarically labeled analytes and fragment ions derived therefrom
US20050147982A1 (en) * 2004-01-05 2005-07-07 Applera Corporation Mixtures of isobarically labeled analytes and fragments ions derived therefrom
US7307169B2 (en) 2004-01-05 2007-12-11 Applera Corporation Isotopically enriched N-substituted piperazines and methods for the preparation thereof
US20050147985A1 (en) * 2004-01-05 2005-07-07 Applera Corporation Mixtures of isobarically labeled analytes and fragments ions derived therefrom
US7355045B2 (en) * 2004-01-05 2008-04-08 Applera Corporation Isotopically enriched N-substituted piperazine acetic acids and methods for the preparation thereof
US20060172319A1 (en) * 2004-07-12 2006-08-03 Applera Corporation Mass tags for quantitative analyses

Also Published As

Publication number Publication date
US20100112708A1 (en) 2010-05-06
US20110217720A1 (en) 2011-09-08
US20110045516A1 (en) 2011-02-24
EP1588145A4 (de) 2007-05-16
US7195751B2 (en) 2007-03-27
US20040219685A1 (en) 2004-11-04
US7947513B2 (en) 2011-05-24
JP4613299B2 (ja) 2011-01-12
WO2004070352A3 (en) 2006-09-28
WO2004070352A2 (en) 2004-08-19
US20060105416A1 (en) 2006-05-18
US8679773B2 (en) 2014-03-25
US20070141659A1 (en) 2007-06-21
AU2008250877A1 (en) 2008-12-18
US20040219686A1 (en) 2004-11-04
AU2004209401A1 (en) 2004-08-19
JP5503358B2 (ja) 2014-05-28
US20080101989A1 (en) 2008-05-01
CA2488584A1 (en) 2004-08-19
EP1588145A2 (de) 2005-10-26
EP1588145B1 (de) 2011-07-06
CA2488584C (en) 2011-10-11
US7799576B2 (en) 2010-09-21
US20040220412A1 (en) 2004-11-04
US7910059B2 (en) 2011-03-22
JP2010190902A (ja) 2010-09-02
JP2007525639A (ja) 2007-09-06

Similar Documents

Publication Publication Date Title
ATE515702T1 (de) Verfahren, mixturen, kits und zusammensetzungen bezüglich der analytbestimmung
WO2007100506A3 (en) Mass tags for quantitative analyses
DE602006017365D1 (de) Zusammensetzungen für die identifizierung von adenoviren
DK1815028T3 (da) Mikrobobler til affinitetsseparation
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
GB2451042A (en) Reagents and methods for using human embryonic stem cells to evaluate toxicity of pharmaceutical compounds and other chemicals
PT1206473E (pt) Pirrolocarbazoles e isoindolonas fundidos isomericos
WO2008105896A3 (en) Analyte determination utilizing mass tagging reagents comprising a non-encoded detectable label
WO2006116127A3 (en) Compositions for use in identification of bacteria
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
GB0127704D0 (en) Nucleic acid enrichment
NO20043259L (no) Bindingsproteiner som biosensorer
DK1381697T3 (da) Cirkulær probe-amplifikation (CPA) af ringformede nukleinsyremolekyler
ATE544063T1 (de) Nanoporenvorrichtung und verfahren zur nukleinsäureanalyse
EP1687283A4 (de) Für die bestimmung von fk506 geeignetes verfahren und zusammensetzung
ATE515488T1 (de) Click-chemie zur herstellung von reportermolekülen
ATE479669T1 (de) Markierungsreagentien, markierte analyten, einschliesslich mischungen davon, und davon abgeleitete fragmentionen und verfahren zu deren analyse
SE0301951D0 (sv) New method
DE602005001302D1 (de) Bestimmung von analytcharakteristika auf der grundlage von bindungseigenschaften
DE602006011756D1 (de) Komplexformierungs- und -trennungsverfahren
DE602007012836D1 (de) Cd86- und cd80-rezeptorkonkurrenztests
DE60332600D1 (de) Selektive elution von immobilisierten multiplexierten primerverlängerungsprodukten
CY1108840T1 (el) Μεθοδοι και συνθεσεις για το χαρακτηρισμο ενος ενζυμου συστηματος οξειδοαναγωγικου αντιδραστηριου
DE60220815D1 (de) Nachweis durch serrs in mikrofluidischer umgebung
WO2008127839A3 (en) Compositions for use in identification of bacteria

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties